
GW Pharmaceuticals plc (GWPH) relating to its proposed acquisition by Jazz Pharmaceuticals Public Limited Company. Under the terms of the agreement, GWPH shareholders are expected to receive $200.00 in cash and $20.00 worth of Jazz ordinary shares per GWPH share they own.